New ‘dentist’ test to detect oral cancer will save lives

A new test for oral cancer, which a dentist could perform by simply using a brush to collect cells from a patient’s mouth, is set to be developed by researchers at the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust.

Read more

Fluorescent probe for oral cancer

A trial with human subjects shows that the device can detect tumors at early stages and locate the edges of a tumor during surgery

UC Davis researchers have developed a laser probe for the early detection of oral cancer. A trial with human subjects shows that the device could also be used during surgery to locate the edges of a tumor.

Read more

Gene may hold key to reducing spread of oral cancers

The spread of cancer cells in the tongue may be reduced if a gene that regulates cancer cell migration can be controlled, according to new research at the University of Illinois at Chicago.

Oral cancer is an under-treated and poorly understood disease, says Xiaofeng “Charles” Zhou, assistant professor in the UIC Center for Molecular Biology of Oral Diseases and lead researcher of the study.

Read more

Researchers study relationship of oral cancers and periodontal disease

Barcelona, Spain – Today during the 88th General Session & Exhibition of the International Association for Dental Research, in Barcelona, Spain, presenting author J. Meyle, Justus Liebig University, Giessen, Germany, will present an abstract titled “P. gingivalis Infection and Immune Evasion of Oral Carcinomas.”

Read more

Tumor virus is best predictor of throat cancer survival

COLUMBUS, Ohio – The presence of human papilloma virus, the virus that causes cervical cancer, in tumors is the most important predictor of survival for people diagnosed with oropharyngeal cancer (cancer of the back of the mouth), according to a new study led by a researcher at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

Read more

Molecular imaging allows individualized ‘dose painting’ for head and neck cancers

Study evaluates the use of advanced molecular imaging techniques in the planning of cutting-edge radiotherapy to treat cancerous tumors of the head and neck

SALT LAKE CITY—According to research revealed at SNM’s 57th Annual Meeting, a multi-tracer molecular imaging technique using positron emission tomography (PET) provides detailed information about the physiological processes of cancerous tumors—and could one day help radiation oncologists treat head and neck cancers with precision external-beam radiation therapy and improve the outcomes of therapy.

Read more

Scientists find genes associated with throat cancer through study of over 10,000 subjects

Contact: Winnie Serah Lim
limcp2@gis.a-star.edu.sg
656-808-8013
Agency for Science, Technology and Research (A*STAR), Singapore Read more

U-M study achieves reduced side effects in head and neck cancer treatment

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System Read more

Extracapsular lymph node involvement: A negative prognostic factor for esophageal cancer

Contact: Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
There is increasing evidence to include combined neoadjuvant chemoradiotherapy (CRT) as an alternative to surgical resection alone, to improve survival for locoregional esophageal cancer. More recently, attention has focused on the presence of extracapsular lymph node involvement (LNI), which identifies a subgroup of patients with significantly worse long-term survival. Little is known about the effects of neoadjuvant chemoradiotherapy (CRT) on the presence of extracapsular LNI and its prognostic value in patients with resected esophageal cancer.

Read more

Immune cells predict success of head and neck cancer treatment, U-M study finds

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System Read more

Next Page »